Home Latest China’s CanSino in the COVID-19 phase III vaccine study abroad

China’s CanSino in the COVID-19 phase III vaccine study abroad

by the owl speaks

As its co-founder said on Saturday, Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to begin a Phase III trial of its experimental COVID-19 vaccine.

The success of China in bringing down COVID-19 infections has made it more difficult to perform large-scale vaccine tests and so far only a few countries have agreed to cooperate with them.

“We ‘re in touch with Russia, Brazil, Chile and Saudi Arabia (for the Phase III trial), and it’s still under discussion,” CanSino’s executive director and co-founder, Qiu Dongxu, told an anti-viral drug production conference in Suzhou, eastern China.

He said his Phase III study will probably start “nearly overnight,” and the company is preparing to hire 40,000 participants for the test.

You may also like

Leave a Comment

so